![Hassan Salari](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hassan Salari
Algemeen Directeur bij Posh Cosmeceuticals, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Weitao Wang | M | 39 | 7 jaar | |
Rick Doman | M | - |
EACOM Timber Corp.
![]() EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | 44 jaar |
Moira Ong | F | 49 | 14 jaar | |
Yossef Av-Gay | M | 62 |
University of British Columbia
| 30 jaar |
Daniel Pauly | M | - |
University of British Columbia
| 30 jaar |
Angus Livingstone | M | - |
University of British Columbia
| 36 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Christian Bezy | M | 68 | - | |
Francine Salari | F | 66 | 3 jaar | |
Jeremy Curnock-Cook | M | 74 |
EACOM Timber Corp.
![]() EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | 16 jaar |
Blair Law | M | - | - | |
Ian Mallmann | M | 63 |
University of British Columbia
| 11 jaar |
David Filer | M | 76 | 3 jaar | |
Audrey Lew | F | 59 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 7 jaar |
David A. Nordquist | M | - |
University of British Columbia
| 8 jaar |
Derek Hemmes | M | - |
University of British Columbia
| 10 jaar |
Sebastian Jaimungal | M | - |
University of British Columbia
| 5 jaar |
Monica Thornton-Trump | F | - |
University of British Columbia
| 7 jaar |
Teck Seng Low | M | 69 |
The University of Southampton
| 8 jaar |
Akio Tanaka | M | 54 |
University of British Columbia
| 6 jaar |
Richard Azani | M | 65 | 3 jaar | |
Li Zhu | F | - |
University of British Columbia
| 3 jaar |
R. Culter | M | 48 | - | |
Brett Kagetsu | M | 54 |
University of British Columbia
| 8 jaar |
Nick B. Drake | M | - |
University of British Columbia
| 10 jaar |
Timothy Lowinger | M | 60 |
University of British Columbia
| 8 jaar |
Terry Hamilton | M | 61 |
University of British Columbia
| 5 jaar |
Bin Huang | M | 65 | 4 jaar | |
Jonathan Bey | M | 54 |
University of British Columbia
| 5 jaar |
Steve Veitch | M | - |
University of British Columbia
| 5 jaar |
Trevor Robinson | M | - |
University of British Columbia
| 18 jaar |
Wei Jiong Zhang | M | 71 |
University of British Columbia
| 6 jaar |
Patric Ouellette | M | - |
University of British Columbia
| 5 jaar |
John Priatel | M | 58 |
University of British Columbia
| 11 jaar |
Salim Dhanji | M | 44 |
University of British Columbia
| 8 jaar |
David Bridge | M | - |
University of British Columbia
| 6 jaar |
Dong Xiao Qiu | M | 62 |
University of British Columbia
| 5 jaar |
Frank S. Moyle | M | - |
University of British Columbia
| 9 jaar |
Kong Lok Yip | M | 48 |
University of British Columbia
| 5 jaar |
Chun Ning Shih | M | 60 |
University of British Columbia
| 6 jaar |
Wale Bolorunduro | M | - |
University of British Columbia
| 4 jaar |
Dominique F. Borrelly | M | 63 | 4 jaar | |
Gregory Burnett | M | - |
University of British Columbia
| 6 jaar |
Harrison Cookenboo | M | 65 |
University of British Columbia
| 5 jaar |
Helge Seetzen | M | - |
University of British Columbia
| 11 jaar |
Michelle Robinson | F | 53 |
University of British Columbia
| 6 jaar |
Paul Thomas | M | 50 |
University of British Columbia
| 3 jaar |
Mark W. Chu | M | 57 |
University of British Columbia
| 8 jaar |
Sanjay Bhanot | M | - |
University of British Columbia
| 7 jaar |
Mary Garden | F | 65 |
University of British Columbia
| 6 jaar |
Lola Maksumova | M | - | - | |
Andre Marziali | M | - |
University of British Columbia
| 4 jaar |
Wendi V. Rodrigueza | M | 58 |
University of British Columbia
| 8 jaar |
Douglas Richardson | M | - |
University of British Columbia
| 6 jaar |
Kurt Loewen | M | 54 |
University of British Columbia
| 6 jaar |
Peeyush Varshney | M | 57 |
University of British Columbia
| 8 jaar |
Bashir Jaffer | M | 76 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 2 jaar |
Walter Korz | M | 63 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
Bill Hunter | M | 61 |
University of British Columbia
| 4 jaar |
Jacqueline Simpson | F | - |
University of British Columbia
| 11 jaar |
Robert E. Cohen | M | - |
University of British Columbia
| 11 jaar |
Roger Quick | M | - |
University of British Columbia
| 7 jaar |
Darrin Erickson | M | - |
University of British Columbia
| 5 jaar |
George Gorzynski | M | - |
University of British Columbia
| 4 jaar |
Cyndi Laval | F | - |
University of British Columbia
| 4 jaar |
Arie Page | F | 45 |
University of British Columbia
| 8 jaar |
Claire Huxtable | F | - |
University of British Columbia
| 6 jaar |
Shaun Foy | M | - |
University of British Columbia
| 9 jaar |
Brian Leeners | M | 58 |
University of British Columbia
| 7 jaar |
Jas Saini | M | 65 |
The University of Southampton
| 7 jaar |
Penny White | F | 52 | 1 jaar | |
Andrea Zaradic | F | 58 |
University of British Columbia
| 6 jaar |
William Edward Mufford | M | - |
University of British Columbia
| 6 jaar |
Ying Bin He | M | 62 |
University of British Columbia
| 5 jaar |
Kim Oishi | M | 60 |
University of British Columbia
| 7 jaar |
Mohammad Azab | M | 68 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 1 jaar |
Julien A. François | M | 46 |
University of British Columbia
| 4 jaar |
Rob Edel | M | - |
University of British Columbia
| 5 jaar |
Peter Smith | M | 55 |
University of British Columbia
| 3 jaar |
Peter Hnik | M | - |
University of British Columbia
| 1 jaar |
David Birch | M | - |
The University of Southampton
| 4 jaar |
Indira Samarasekera | M | 71 |
University of British Columbia
| 9 jaar |
John Osth | M | 77 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 4 jaar |
Matthias C. Kurth | M | 68 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 6 jaar |
David Smalley | M | 63 |
University of British Columbia
| 3 jaar |
Marin Katusa | M | 45 |
University of British Columbia
| 4 jaar |
C. Piazza | M | 77 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
Byron Berry | M | - |
University of British Columbia
| 4 jaar |
Brad Willock | M | - |
University of British Columbia
| 6 jaar |
Sean O'Reilly | M | - |
University of British Columbia
| 4 jaar |
Bill M. Gallacher | M | - |
University of British Columbia
| 4 jaar |
Martha C. Piper | M | 78 |
University of British Columbia
| 9 jaar |
Mike J. Dost | M | - |
University of British Columbia
| 2 jaar |
Stephen Kenwood | M | 62 |
University of British Columbia
| 4 jaar |
Yen You Zheng | M | 67 |
University of British Columbia
| 9 jaar |
Brandon Macdonald | M | - |
University of British Columbia
| 4 jaar |
Tim Termuende | M | 61 |
University of British Columbia
| 4 jaar |
Guy Ely | M | 71 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 1 jaar |
Mateusz Szeszkowski | M | 52 |
University of British Columbia
| - |
Donald Evans | M | 59 |
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
Robert King | M | 57 |
University of British Columbia
| 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Canada | 93 | 93.00% |
Hongkong | 4 | 4.00% |
Verenigd Koninkrijk | 3 | 3.00% |
Iran | 0 | -.--% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Hassan Salari
- Persoonlijk netwerk